Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes

IMPORTANCE: Assessing the relative effectiveness and safety of additional treatments when metformin monotherapy is insufficient remains a limiting factor in improving treatment choices in type 2 diabetes. OBJECTIVE: To determine whether data from electronic health records across the University of Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Vashisht, Rohit, Patel, Ayan, Dahm, Lisa, Han, Cora, Medders, Kathryn E., Mowers, Robert, Byington, Carrie L., Koliwad, Suneil K., Butte, Atul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546239/
https://www.ncbi.nlm.nih.gov/pubmed/37782497
http://dx.doi.org/10.1001/jamanetworkopen.2023.36613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546239/
https://www.ncbi.nlm.nih.gov/pubmed/37782497
http://dx.doi.org/10.1001/jamanetworkopen.2023.36613

Ejemplares similares